East Africa: KUTRRH Introduces Groundbreaking Prostate Cancer Therapy in East Africa

27 January 2026
Capital FM (Nairobi)

Nairobi — The Kenyatta University Teaching, Referral and Research Hospital (KUTRRH) has made a major leap in cancer care, becoming the first public hospital in the region to offer Lutetium-177 PSMA therapy.

The targeted, innovative treatment delivers radiation directly to cancer cells, offering new hope for patients with advanced prostate cancer who no longer respond to conventional therapies.

By focusing on cancerous cells, the therapy reduces side effects while improving patient outcomes.

"This advancement reinforces our commitment to world-class, accessible cancer care," said Dr. Zeinab Gura, CEO of KUTRRH.

The facility hailed the introduction of Lutetium-177 PSMA therapy as a milestone in bringing life-saving innovations closer to Kenyan and East African communities, supporting the broader goal of Universal Health Coverage (UHC) and strengthening the region's capacity to manage complex cancers.

Read the original article on Capital FM.

Tagged:
Copyright © 2026 Capital FM. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 400 reports a day from more than 80 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.